Mentioned:
HIMS -6.50% NVO
Hims & Hers Health has been dominating the telemedicine opportunity in the United States of America. And now, they’re raising nearly a billion dollars in debt to fuel their expansion plans.
What’s happening:
- Hims & Hers Health (NYSE: HIMS) has officially increased the size of their convertible note financing to $870M USD
By the numbers:
- Hims & Hers Health initially set out to raise $450M USD in convertible notes prior to upsizing the round
- The new convertible note financing has a 0.00% interest rate and will be redeemable for either common shares or cash in the future
Why it matters:
- This is the largest debt funding round that Hims & Hers Health has ever raised since becoming a publicly traded company
Going deeper:
- Novo Nordisk (NYSE: NVO) and Hims & Hers Health just recently made waves when they formed a new partnership to expand access to weight loss drugs, including Novo Nordic’s highly popular GLP-1 drug Wegovy
- Hims & Hers Health has also been ramping up acquisitions lately, including previously acquiring at home blood testing startup Trybe Labs


